BioGaia signs a distribution agreement with Recordati in Italy
BioGaia has entered into an exclusive distribution agreement with Recordati in Italy for BioGaia’s probiotic products. BioGaia signed a long-term agreement establishing a direct relationship with Recordati for the exclusive distribution of probiotics in the Italian market. Recordati is a global pharmaceutical company listed on the Italian stock exchange, with over 4,450 employees and operations in multiple markets worldwide. BioGaia already operates in partnership with Recordati in Spain and Portugal. The agreement replaces a previous sub-license and directly grants Recordati